Cyclophosphamide for Injection, USP
Another addition to the growing Fresenius Kabi oncology portfolio.
Fresenius Kabi continues to deliver the most extensive generic injectable oncology portfolio – working together with care teams across the country to support oncology patients.
Another addition to the growing Fresenius Kabi oncology portfolio.